Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Forte Biosciences, Inc. (FBRX) Payables (2016 - 2020)

Forte Biosciences (FBRX) has disclosed Payables for 5 consecutive years, with $1.5 million as the latest value for Q3 2020.

  • On a quarterly basis, Payables fell 94.98% to $1.5 million in Q3 2020 year-over-year; TTM through Sep 2020 was $1.5 million, a 94.98% decrease, with the full-year FY2019 number at $6.3 million, up 85.46% from a year prior.
  • Payables was $1.5 million for Q3 2020 at Forte Biosciences, down from $2.6 million in the prior quarter.
  • In the past five years, Payables ranged from a high of $30.1 million in Q3 2019 to a low of $1.5 million in Q2 2018.
  • A 5-year average of $7.5 million and a median of $6.8 million in 2019 define the central range for Payables.
  • Peak YoY movement for Payables: surged 561.6% in 2019, then plummeted 94.98% in 2020.
  • Forte Biosciences' Payables stood at $8.9 million in 2016, then rose by 3.21% to $9.2 million in 2017, then crashed by 62.8% to $3.4 million in 2018, then soared by 85.46% to $6.3 million in 2019, then tumbled by 76.03% to $1.5 million in 2020.
  • Per Business Quant, the three most recent readings for FBRX's Payables are $1.5 million (Q3 2020), $2.6 million (Q2 2020), and $6.6 million (Q1 2020).